Publications by authors named "Daniel Feikin"

Claim this Profile
G
Global disparities in the introduction, scale-up, and effectiveness evaluation of COVID-19 vaccines.
Martina Pesce, Daniel R Feikin, Melissa M Higdon, Katherine L O'Brien, Minal K Patel

Nat Commun· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Designing effectiveness and impact studies for respiratory syncytial virus immunisation in low- and middle-income countries.
Rita Reyburn, Fiona M Russell, Patrick K Munywoki, Lauren Franzel, Tran T G Huong, Daniel Feikin

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical approaches and examples of addressing time-varying factors in COVID-19 vaccine effectiveness studies: Report from a meeting of the World Health Organization.
Anshu Varma, Nick J Andrews, Sara Carazo, Karoline Walter, Esther Kissling, Daniel R Feikin

Vaccine· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference.
Vincent Bauchau, Kaatje Bollaerts, Phil Bryan, Jim Buttery, Kourtney Davis, Daniel R Feikin

Drug Saf· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the current evidence base for measles vaccination earlier than 9 months of age?: Report from an informal technical consultation of the World Health Organization.
Anshu Varma, Shelly Bolotin, Gaston De Serres, Arnaud M Didierlaurent, Kristen Earle, Daniel R Feikin

Vaccine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis.
Julia C Bennett, Maria Deloria Knoll, Eunice W Kagucia, Maria Garcia Quesada, Scott L Zeger, Daniel R Feikin

Lancet Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.
Maria Garcia Quesada, Meagan E Peterson, Julia C Bennett, Kyla Hayford, Scott L Zeger, Daniel R Feikin

Lancet Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the Pneumonia Etiology Research for Child Health (PERCH) study experience.
Ryo Miyakawa, Haijun Zhang, W Abdullah Brooks, Christine Prosperi, Henry C Baggett, Daniel R Feikin

Clin Microbiol Infect· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project.
Yangyupei Yang, Maria Deloria Knoll, Carly Herbert, Julia C Bennett, Daniel R Feikin

J Infect· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemic.
Chenkai Zhao, Tiantian Zhang, Ling Guo, Shiqi Sun, Yumeng Miao, Daniel R Feikin

Nat Commun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access.
Jonne Terstappen, Sarah F Hak, Anant Bhan, Debby Bogaert, Louis J Bont, Daniel R Feikin

Lancet Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children.
Clint Pecenka, Erin Sparrow, Daniel R Feikin, Padmini Srikantiah, Delese Mimi Darko

Lancet· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccine Uptake and Effectiveness by Time since Vaccination in the Western Cape Province, South Africa: An Observational Cohort Study during 2020-2022.
Reshma Kassanjee, Mary-Ann Davies, Alexa Heekes, Hassan Mahomed, Anthony J Hawkridge, Daniel R Feikin

Vaccines (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The full value of immunisation against respiratory syncytial virus for infants younger than 1 year: effects beyond prevention of acute respiratory illness.
Daniel R Feikin, Ruth A Karron, Samir K Saha, Erin Sparrow, Padmini Srikantiah

Lancet Infect Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis.
Bingbing Cong, Uğurcan Koç, Teresa Bandeira, Quique Bassat, Louis Bont, Daniel R Feikin

Lancet Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Informing the pandemic response: the role of the WHO's COVID-19 Weekly Epidemiological Update.
Juniorcaius Ikejezie, Alessandro Miglietta, Ingrid Hammermeister Nezu, Sandra Adele, Melissa M Higdon, Daniel Feikin

BMJ Glob Health· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors predicting mortality in hospitalised HIV-negative children with lower-chest-wall indrawing pneumonia and implications for management.
Katherine E Gallagher, Juliet O Awori, Maria D Knoll, Julia Rhodes, Melissa M Higdon, Daniel R Feikin

PLoS One· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EXAMINING BIAS FROM DIFFERENTIAL DEPLETION OF SUSCEPTIBLES IN VACCINE EFFECTIVENESS ESTIMATES IN SETTINGS OF WANING.
Rebecca Kahn, Daniel R Feikin, Ryan E Wiegand, Marc Lipsitch

Am J Epidemiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccine uptake and effectiveness by time since vaccination in the Western Cape province, South Africa: An observational cohort study during 2020-2022.
Reshma Kassanjee, Mary-Ann Davies, Alexa Heekes, Hassan Mahomed, Anthony J Hawkridge, Daniel Feikin

medRxiv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are bivalent vaccines better than ancestral-virus monovalent vaccines in protecting against severe omicron COVID-19?
Shabir A Madhi, Daniel R Feikin

Lancet Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value profile for respiratory syncytial virus vaccines and monoclonal antibodies.
Jessica A Fleming, Ranju Baral, Deborah Higgins, Sadaf Khan, Sonali Kochar, Daniel Feikin

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of the WHO technical consultation on the evaluation of respiratory syncytial virus prevention cost effectiveness in low- and middle-income countries, April 7-8, 2022.
Meagan C Fitzpatrick, Rachel S Laufer, Ranju Baral, Amanda J Driscoll, Daniel R Feikin

Vaccine· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.
Niklas Bobrovitz, Harriet Ware, Xiaomeng Ma, Zihan Li, Reza Hosseini, Daniel R Feikin

Lancet Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization.
Daniel R Feikin, Melissa M Higdon, Nick Andrews, Shirley Collie, Maria Deloria Knoll

Vaccine· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.
Natalie I Mazur, Jonne Terstappen, Ranju Baral, Azucena Bardají, Philippe Beutels, Daniel Feikin

Lancet Infect Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis